• LAST PRICE
    15.6300
  • TODAY'S CHANGE (%)
    Trending Down-0.2600 (-1.6362%)
  • Bid / Lots
    15.5600/ 4
  • Ask / Lots
    15.6200/ 4
  • Open / Previous Close
    15.7400 / 15.8900
  • Day Range
    Low 15.5200
    High 16.1500
  • 52 Week Range
    Low 12.9500
    High 25.4700
  • Volume
    91,538
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 15.89
TimeVolumeRCUS
09:32 ET317815.7
09:34 ET245015.79
09:36 ET130315.794
09:38 ET10015.78
09:39 ET140015.79
09:41 ET10015.8348
09:43 ET54215.85
09:45 ET50015.9
09:48 ET223915.98
09:50 ET44315.97
09:52 ET20016.04
09:54 ET20016.06
09:56 ET20016.15
09:59 ET60016.135
10:01 ET77016.0799
10:03 ET50015.95
10:06 ET50015.9
10:08 ET138315.865
10:10 ET70015.76
10:12 ET72315.75
10:14 ET142815.81
10:15 ET28015.88
10:17 ET168815.87
10:19 ET24415.85
10:21 ET10015.8
10:26 ET18915.815
10:28 ET80015.8292
10:30 ET45515.79
10:32 ET502515.7881
10:33 ET238615.79
10:35 ET10015.775
10:37 ET40015.7
10:39 ET40015.68
10:42 ET20015.65
10:44 ET40015.66
10:46 ET82115.72
10:50 ET70015.7
10:51 ET20015.685
10:55 ET26515.62
10:57 ET20015.62
11:02 ET55015.66
11:04 ET509815.655
11:06 ET51515.69
11:08 ET174615.67
11:09 ET512915.69
11:11 ET73715.65
11:15 ET10015.63
11:20 ET104115.69
11:22 ET20015.69
11:24 ET11115.68
11:26 ET40415.67
11:29 ET71415.64
11:31 ET197215.615
11:33 ET10015.6
11:36 ET283515.6125
11:38 ET82515.59
11:40 ET252415.58
11:42 ET80315.55
11:44 ET30015.55
11:45 ET88915.53
11:47 ET70015.53
11:49 ET51615.55
11:51 ET30115.53
11:56 ET60015.54
11:58 ET80015.59
12:00 ET48815.57
12:02 ET10015.62
12:03 ET72215.63
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRCUS
Arcus Biosciences Inc
1.4B
-5.0x
---
United StatesARDX
Ardelyx Inc
1.5B
-20.7x
---
United StatesGYRE
Gyre Therapeutics Inc
1.3B
-8.1x
---
United StatesVIR
Vir Biotechnology Inc
1.4B
-2.6x
---
United StatesNRIX
Nurix Therapeutics Inc
1.5B
-7.4x
---
United StatesPRTA
Prothena Corporation PLC
1.3B
-7.4x
---
As of 2024-07-17

Company Information

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.

Contact Information

Headquarters
3928 Point Eden WayHAYWARD, CA, United States 94545-3719
Phone
510-694-6200
Fax
302-730-1370

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Terry Rosen
President, Co-Founder
Juan Jaen
Chief Financial Officer
Robert Goeltz
Chief Operating Officer
Jennifer Jarrett
General Counsel
Carolyn Tang

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4B
Revenue (TTM)
$237.0M
Shares Outstanding
91.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.89
EPS
$-3.10
Book Value
$6.12
P/E Ratio
-5.0x
Price/Sales (TTM)
6.1
Price/Cash Flow (TTM)
---
Operating Margin
-113.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.